fda warning letter compounding semaglutide october 2025 issued 25 letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Novo Nordisk Calls for FDA

However, the recommended dosage for Ozempic is as follows: After the patient is cleared to use Ozempic, a nutrition and workout plan will be curated that we have found works best to support Ozempic

Development and approval of rybelsus (oral semaglutide): ushering in a new era in peptide delivery

According to a recent report by Morgan Stanley, the global market for obesity drugs is expected to increase 15-fold by 2030, driven by their expanding use beyond weight loss to address various obesity-related conditions

Copperbinding peptides like GHKCu and related complexes can act as antioxidants or SOD mimetics in skin models, helping to reduce oxidative damage in local tissues